시장조사 보고서 : 세계의 항소화성 궤양 치료약 시장예측 2021년-2026년

■ 영문 제목 : Global Anti Peptic Ulcer Drugs Market Growth 2021-2026
	■ 상품코드 : LPI-2108K201064 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 8월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 163 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (20명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 항소화성 궤양 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (양자 펌프 억제제 (PPI), 칼륨-경쟁 산 차단제 (P-CAB), 제산제, H2 길항제, 항생제, 궤양 보호제)와 용도별 시장규모 (위염, 위궤양, 십이지장 궤양, 위식도 역류 병 (GERD)) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 항소화성 궤양 치료약 시장 점유율
- 지역별 항소화성 궤양 치료약 시장규모
- 주요지역의 종류별 시장규모 (양자 펌프 억제제 (PPI), 칼륨-경쟁 산 차단제 (P-CAB), 제산제, H2 길항제, 항생제, 궤양 보호제)
- 주요지역의 용도별 시장규모 (위염, 위궤양, 십이지장 궤양, 위식도 역류 병 (GERD))
- 미주의 항소화성 궤양 치료약 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 항소화성 궤양 치료약 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 항소화성 궤양 치료약 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 항소화성 궤양 치료약 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 항소화성 궤양 치료약 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2020 growth of Anti Peptic Ulcer Drugs will have significant change from previous year. By the most conservative estimates of global Anti Peptic Ulcer Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Anti Peptic Ulcer Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti Peptic Ulcer Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Proton Pump Inhibitors (PPIs)
Potassium-Competitive Acid Blockers (P-CAB)
Antacids
H2 Antagonists
Antibiotics
Ulcer Protective Drugs

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Gastritis
Gastric Ulcers
Duodenal Ulcers
Gastroesophageal Reflux Disease (GERD)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Eisai
Daewoong Pharmaceutical
Takeda Pharmaceutical
HeliCure
AstraZeneca
Ore Pharmaceuticals
Sihuan Pharmaceutical
GlaxoSmithKline
Pfizer
Abbott Laboratories
Yuhan Corporation
Cadila Healthcare
Boehringer Ingelheim

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti Peptic Ulcer Drugs Consumption 2016-2026
2.1.2 Anti Peptic Ulcer Drugs Consumption CAGR by Region
2.2 Anti Peptic Ulcer Drugs Segment by Type
2.2.1 Proton Pump Inhibitors (PPIs)
2.2.2 Potassium-Competitive Acid Blockers (P-CAB)
2.2.3 Antacids
2.2.4 H2 Antagonists
2.2.5 Antibiotics
2.2.6 Ulcer Protective Drugs
2.3 Anti Peptic Ulcer Drugs Sales by Type
2.3.1 Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Anti Peptic Ulcer Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Anti Peptic Ulcer Drugs Sale Price by Type (2016-2021)
2.4 Anti Peptic Ulcer Drugs Segment by Application
2.4.1 Gastritis
2.4.2 Gastric Ulcers
2.4.3 Duodenal Ulcers
2.4.4 Gastroesophageal Reflux Disease (GERD)
2.5 Anti Peptic Ulcer Drugs Sales by Application
2.5.1 Global Anti Peptic Ulcer Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Anti Peptic Ulcer Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Anti Peptic Ulcer Drugs Sale Price by Application (2016-2021)

3 Global Anti Peptic Ulcer Drugs by Company
3.1 Global Anti Peptic Ulcer Drugs Sales Market Share by Company
3.1.1 Global Anti Peptic Ulcer Drugs Sales by Company (2019-2021)
3.1.2 Global Anti Peptic Ulcer Drugs Sales Market Share by Company (2019-2021)
3.2 Global Anti Peptic Ulcer Drugs Revenue Market Share by Company
3.2.1 Global Anti Peptic Ulcer Drugs Revenue by Company (2019-2021)
3.2.2 Global Anti Peptic Ulcer Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Anti Peptic Ulcer Drugs Sale Price by Company
3.4 Global Manufacturers Anti Peptic Ulcer Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti Peptic Ulcer Drugs Product Location Distribution
3.4.2 Players Anti Peptic Ulcer Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Anti Peptic Ulcer Drugs by Region
4.1 Global Anti Peptic Ulcer Drugs by Region
4.1.1 Global Anti Peptic Ulcer Drugs Sales by Region
4.1.2 Global Anti Peptic Ulcer Drugs Revenue by Region
4.2 Americas Anti Peptic Ulcer Drugs Sales Growth
4.3 APAC Anti Peptic Ulcer Drugs Sales Growth
4.4 Europe Anti Peptic Ulcer Drugs Sales Growth
4.5 Middle East & Africa Anti Peptic Ulcer Drugs Sales Growth

5 Americas
5.1 Americas Anti Peptic Ulcer Drugs Sales by Country
5.1.1 Americas Anti Peptic Ulcer Drugs Sales by Country (2016-2021)
5.1.2 Americas Anti Peptic Ulcer Drugs Revenue by Country (2016-2021)
5.2 Americas Anti Peptic Ulcer Drugs Sales by Type
5.3 Americas Anti Peptic Ulcer Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Anti Peptic Ulcer Drugs Sales by Region
6.1.1 APAC Anti Peptic Ulcer Drugs Sales by Region (2016-2021)
6.1.2 APAC Anti Peptic Ulcer Drugs Revenue by Region (2016-2021)
6.2 APAC Anti Peptic Ulcer Drugs Sales by Type
6.3 APAC Anti Peptic Ulcer Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Anti Peptic Ulcer Drugs by Country
7.1.1 Europe Anti Peptic Ulcer Drugs Sales by Country (2016-2021)
7.1.2 Europe Anti Peptic Ulcer Drugs Revenue by Country (2016-2021)
7.2 Europe Anti Peptic Ulcer Drugs Sales by Type
7.3 Europe Anti Peptic Ulcer Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Anti Peptic Ulcer Drugs by Country
8.1.1 Middle East & Africa Anti Peptic Ulcer Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Anti Peptic Ulcer Drugs Sales by Type
8.3 Middle East & Africa Anti Peptic Ulcer Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anti Peptic Ulcer Drugs Distributors
10.3 Anti Peptic Ulcer Drugs Customer

11 Global Anti Peptic Ulcer Drugs Market Forecast
11.1 Global Anti Peptic Ulcer Drugs Forecast by Region
11.1.1 Global Anti Peptic Ulcer Drugs Forecast by Regions (2021-2026)
11.2.2 Global Anti Peptic Ulcer Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Anti Peptic Ulcer Drugs Forecast by Type
11.7 Global Anti Peptic Ulcer Drugs Forecast by Application

12 Key Players Analysis
12.1 Eisai
12.1.1 Eisai Eisai Company Information
12.1.2 Eisai Anti Peptic Ulcer Drugs Product Offered
12.1.3 Eisai Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Eisai Main Business Overview
12.1.5 Eisai Latest Developments
12.2 Daewoong Pharmaceutical
12.2.1 Daewoong Pharmaceutical Company Information
12.2.2 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
12.2.3 Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Daewoong Pharmaceutical Main Business Overview
12.2.5 Daewoong Pharmaceutical Latest Developments
12.3 Takeda Pharmaceutical
12.3.1 Takeda Pharmaceutical Company Information
12.3.2 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
12.3.3 Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Takeda Pharmaceutical Main Business Overview
12.3.5 Takeda Pharmaceutical Latest Developments
12.4 HeliCure
12.4.1 HeliCure Company Information
12.4.2 HeliCure Anti Peptic Ulcer Drugs Product Offered
12.4.3 HeliCure Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 HeliCure Main Business Overview
12.4.5 HeliCure Latest Developments
12.5 AstraZeneca
12.5.1 AstraZeneca Company Information
12.5.2 AstraZeneca Anti Peptic Ulcer Drugs Product Offered
12.5.3 AstraZeneca Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 AstraZeneca Main Business Overview
12.5.5 AstraZeneca Latest Developments
12.6 Ore Pharmaceuticals
12.6.1 Ore Pharmaceuticals Company Information
12.6.2 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Product Offered
12.6.3 Ore Pharmaceuticals Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Ore Pharmaceuticals Main Business Overview
12.6.5 Ore Pharmaceuticals Latest Developments
12.7 Sihuan Pharmaceutical
12.7.1 Sihuan Pharmaceutical Company Information
12.7.2 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
12.7.3 Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Sihuan Pharmaceutical Main Business Overview
12.7.5 Sihuan Pharmaceutical Latest Developments
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Company Information
12.8.2 GlaxoSmithKline Anti Peptic Ulcer Drugs Product Offered
12.8.3 GlaxoSmithKline Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 GlaxoSmithKline Main Business Overview
12.8.5 GlaxoSmithKline Latest Developments
12.9 Pfizer
12.9.1 Pfizer Company Information
12.9.2 Pfizer Anti Peptic Ulcer Drugs Product Offered
12.9.3 Pfizer Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Pfizer Main Business Overview
12.9.5 Pfizer Latest Developments
12.10 Abbott Laboratories
12.10.1 Abbott Laboratories Company Information
12.10.2 Abbott Laboratories Anti Peptic Ulcer Drugs Product Offered
12.10.3 Abbott Laboratories Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Abbott Laboratories Main Business Overview
12.10.5 Abbott Laboratories Latest Developments
12.11 Yuhan Corporation
12.11.1 Yuhan Corporation Company Information
12.11.2 Yuhan Corporation Anti Peptic Ulcer Drugs Product Offered
12.11.3 Yuhan Corporation Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Yuhan Corporation Main Business Overview
12.11.5 Yuhan Corporation Latest Developments
12.12 Cadila Healthcare
12.12.1 Cadila Healthcare Company Information
12.12.2 Cadila Healthcare Anti Peptic Ulcer Drugs Product Offered
12.12.3 Cadila Healthcare Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Cadila Healthcare Main Business Overview
12.12.5 Cadila Healthcare Latest Developments
12.13 Boehringer Ingelheim
12.13.1 Boehringer Ingelheim Company Information
12.13.2 Boehringer Ingelheim Anti Peptic Ulcer Drugs Product Offered
12.13.3 Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Boehringer Ingelheim Main Business Overview
12.13.5 Boehringer Ingelheim Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Anti Peptic Ulcer Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Proton Pump Inhibitors (PPIs)
Table 3. Major Players of Potassium-Competitive Acid Blockers (P-CAB)
Table 4. Major Players of Antacids
Table 5. Major Players of H2 Antagonists
Table 6. Major Players of Antibiotics
Table 7. Major Players of Ulcer Protective Drugs
Table 8. Global Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 9. Global Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 10. Global Anti Peptic Ulcer Drugs Revenue by Type (2016-2021) & ($ million)
Table 11. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2016-2021)
Table 12. Global Anti Peptic Ulcer Drugs Sale Price by Type (2016-2021)
Table 13. Global Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 14. Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 15. Global Anti Peptic Ulcer Drugs Value by Application (2016-2021)
Table 16. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application (2016-2021)
Table 17. Global Anti Peptic Ulcer Drugs Sale Price by Application (2016-2021)
Table 18. Global Anti Peptic Ulcer Drugs Sales by Company (2019-2021) & (K Units)
Table 19. Global Anti Peptic Ulcer Drugs Sales Market Share by Company (2019-2021)
Table 20. Global Anti Peptic Ulcer Drugs Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Anti Peptic Ulcer Drugs Revenue Market Share by Company (2019-2021)
Table 22. Global Anti Peptic Ulcer Drugs Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Anti Peptic Ulcer Drugs Producing Area Distribution and Sales Area
Table 24. Players Anti Peptic Ulcer Drugs Products Offered
Table 25. Anti Peptic Ulcer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Anti Peptic Ulcer Drugs Sales by Region (2016-2021) (K Units)
Table 29. Global Anti Peptic Ulcer Drugs Sales Market Share by Region (2016-2021)
Table 30. Global Anti Peptic Ulcer Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region (2016-2021)
Table 32. Americas Anti Peptic Ulcer Drugs Sales by Country (2016-2021) & (K Units)
Table 33. Americas Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2021)
Table 34. Americas Anti Peptic Ulcer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2021)
Table 36. Americas Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 37. Americas Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 38. Americas Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 39. Americas Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 40. APAC Anti Peptic Ulcer Drugs Sales by Region (2016-2021) & (K Units)
Table 41. APAC Anti Peptic Ulcer Drugs Sales Market Share by Region (2016-2021)
Table 42. APAC Anti Peptic Ulcer Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Anti Peptic Ulcer Drugs Revenue Market Share by Region (2016-2021)
Table 44. APAC Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 45. APAC Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 46. APAC Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 47. APAC Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 48. Europe Anti Peptic Ulcer Drugs Sales by Country (2016-2021) & (K Units)
Table 49. Europe Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2021)
Table 50. Europe Anti Peptic Ulcer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2021)
Table 52. Europe Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 53. Europe Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 54. Europe Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 55. Europe Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Country (2016-2021) & (K Units)
Table 57. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Anti Peptic Ulcer Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Anti Peptic Ulcer Drugs Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Type (2016-2021) & (K Units)
Table 61. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Anti Peptic Ulcer Drugs Sales by Application (2016-2021) & (K Units)
Table 63. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Table 64. Global Anti Peptic Ulcer Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 65. Global Anti Peptic Ulcer Drugs Sales Market Share Forecast by Type (2021-2026)
Table 66. Global Anti Peptic Ulcer Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 67. Global Anti Peptic Ulcer Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 68. Global Anti Peptic Ulcer Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 69. Global Anti Peptic Ulcer Drugs Sales Market Share Forecast by Application (2021-2026)
Table 70. Global Anti Peptic Ulcer Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 71. Global Anti Peptic Ulcer Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 72. Eisai Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 73. Eisai Anti Peptic Ulcer Drugs Product Offered
Table 74. Eisai Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 75. Eisai Main Business
Table 76. Eisai Latest Developments
Table 77. Daewoong Pharmaceutical Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 78. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
Table 79. Daewoong Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 80. Daewoong Pharmaceutical Main Business
Table 81. Daewoong Pharmaceutical Latest Developments
Table 82. Takeda Pharmaceutical Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 83. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
Table 84. Takeda Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 85. Takeda Pharmaceutical Main Business
Table 86. Takeda Pharmaceutical Latest Developments
Table 87. HeliCure Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 88. HeliCure Anti Peptic Ulcer Drugs Product Offered
Table 89. HeliCure Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 90. HeliCure Main Business
Table 91. HeliCure Latest Developments
Table 92. AstraZeneca Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. AstraZeneca Anti Peptic Ulcer Drugs Product Offered
Table 94. AstraZeneca Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Latest Developments
Table 97. Ore Pharmaceuticals Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Ore Pharmaceuticals Anti Peptic Ulcer Drugs Product Offered
Table 99. Ore Pharmaceuticals Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 100. Ore Pharmaceuticals Main Business
Table 101. Ore Pharmaceuticals Latest Developments
Table 102. Sihuan Pharmaceutical Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Product Offered
Table 104. Sihuan Pharmaceutical Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 105. Sihuan Pharmaceutical Main Business
Table 106. Sihuan Pharmaceutical Latest Developments
Table 107. GlaxoSmithKline Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. GlaxoSmithKline Anti Peptic Ulcer Drugs Product Offered
Table 109. GlaxoSmithKline Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 110. GlaxoSmithKline Main Business
Table 111. GlaxoSmithKline Latest Developments
Table 112. Pfizer Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Anti Peptic Ulcer Drugs Product Offered
Table 114. Pfizer Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Abbott Laboratories Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Abbott Laboratories Anti Peptic Ulcer Drugs Product Offered
Table 119. Abbott Laboratories Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 120. Abbott Laboratories Main Business
Table 121. Abbott Laboratories Latest Developments
Table 122. Yuhan Corporation Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Yuhan Corporation Anti Peptic Ulcer Drugs Product Offered
Table 124. Yuhan Corporation Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 125. Yuhan Corporation Main Business
Table 126. Yuhan Corporation Latest Developments
Table 127. Cadila Healthcare Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Cadila Healthcare Anti Peptic Ulcer Drugs Product Offered
Table 129. Cadila Healthcare Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 130. Cadila Healthcare Main Business
Table 131. Cadila Healthcare Latest Developments
Table 132. Boehringer Ingelheim Basic Information, Anti Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Ingelheim Anti Peptic Ulcer Drugs Product Offered
Table 134. Boehringer Ingelheim Anti Peptic Ulcer Drugs Sales (K Units), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)
Table 135. Boehringer Ingelheim Main Business
Table 136. Boehringer Ingelheim Latest Developments
List of Figures
Figure 1. Picture of Anti Peptic Ulcer Drugs
Figure 2. Anti Peptic Ulcer Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti Peptic Ulcer Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Anti Peptic Ulcer Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Anti Peptic Ulcer Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Proton Pump Inhibitors (PPIs)
Figure 10. Product Picture of Potassium-Competitive Acid Blockers (P-CAB)
Figure 11. Product Picture of Antacids
Figure 12. Product Picture of H2 Antagonists
Figure 13. Product Picture of Antibiotics
Figure 14. Product Picture of Ulcer Protective Drugs
Figure 15. Global Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 16. Global Anti Peptic Ulcer Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Anti Peptic Ulcer Drugs Consumed in Gastritis
Figure 18. Global Anti Peptic Ulcer Drugs Market: Gastritis (2016-2021) & (K Units)
Figure 19. Anti Peptic Ulcer Drugs Consumed in Gastric Ulcers
Figure 20. Global Anti Peptic Ulcer Drugs Market: Gastric Ulcers (2016-2021) & (K Units)
Figure 21. Anti Peptic Ulcer Drugs Consumed in Duodenal Ulcers
Figure 22. Global Anti Peptic Ulcer Drugs Market: Duodenal Ulcers (2016-2021) & (K Units)
Figure 23. Anti Peptic Ulcer Drugs Consumed in Gastroesophageal Reflux Disease (GERD)
Figure 24. Global Anti Peptic Ulcer Drugs Market: Gastroesophageal Reflux Disease (GERD) (2016-2021) & (K Units)
Figure 25. Global Anti Peptic Ulcer Drugs Sales Market Share by Application (2016-2021)
Figure 26. Global Anti Peptic Ulcer Drugs Revenue Market Share by Application in 2020
Figure 27. Global Anti Peptic Ulcer Drugs Revenue Market by Company in 2020 ($ Million)
Figure 28. Global Anti Peptic Ulcer Drugs Revenue Market Share by Company in 2020
Figure 29. Global Anti Peptic Ulcer Drugs Sales Market Share by Regions (2016-2021)
Figure 30. Global Anti Peptic Ulcer Drugs Revenue Market Share by Region in 2020
Figure 31. Americas Anti Peptic Ulcer Drugs Sales 2016-2021 (K Units)
Figure 32. Americas Anti Peptic Ulcer Drugs Revenue 2016-2021 ($ Millions)
Figure 33. APAC Anti Peptic Ulcer Drugs Sales 2016-2021 (K Units)
Figure 34. APAC Anti Peptic Ulcer Drugs Revenue 2016-2021 ($ Millions)
Figure 35. Europe Anti Peptic Ulcer Drugs Sales 2016-2021 (K Units)
Figure 36. Europe Anti Peptic Ulcer Drugs Revenue 2016-2021 ($ Millions)
Figure 37. Middle East & Africa Anti Peptic Ulcer Drugs Sales 2016-2021 (K Units)
Figure 38. Middle East & Africa Anti Peptic Ulcer Drugs Revenue 2016-2021 ($ Millions)
Figure 39. Americas Anti Peptic Ulcer Drugs Sales Market Share by Country in 2020
Figure 40. Americas Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2020
Figure 41. Americas Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 42. Americas Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 43. United States Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 44. Canada Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 45. Mexico Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 46. Brazil Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. APAC Anti Peptic Ulcer Drugs Sales Market Share by Region in 2020
Figure 48. APAC Anti Peptic Ulcer Drugs Revenue Market Share by Regions in 2020
Figure 49. APAC Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 50. APAC Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 51. China Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Japan Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 53. Korea Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 54. Southeast Asia Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 55. India Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 56. Australia Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. Europe Anti Peptic Ulcer Drugs Sales Market Share by Country in 2020
Figure 58. Europe Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2020
Figure 59. Europe Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 60. Europe Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 61. Germany Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 62. France Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 63. UK Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 64. Italy Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 65. Russia Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Country in 2020
Figure 67. Middle East & Africa Anti Peptic Ulcer Drugs Revenue Market Share by Country in 2020
Figure 68. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Type in 2020
Figure 69. Middle East & Africa Anti Peptic Ulcer Drugs Sales Market Share by Application in 2020
Figure 70. Egypt Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 71. South Africa Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 72. Israel Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 73. Turkey Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 74. GCC Country Anti Peptic Ulcer Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles

※본 조사보고서 [세계의 항소화성 궤양 치료약 시장예측 2021년-2026년] (코드 : LPI-2108K201064) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 항소화성 궤양 치료약 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 항비만약 시장예측 2021년-2026년
LPI-2108K200019 / LP Information / 2021년 8월 / 본 조사보고서는 항비만약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Anti Obesity Drugs will have significant change from previous year. By the most conservative estimates of global Anti Obesity Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 감량 치료제 시장예측 2021년-2026년
LPI-2108K200004 / LP Information / 2021년 8월 / 본 조사보고서는 감량 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Weight Loss Drugs will have significant change from previous year. By the most conservative estimates of global Weight Loss Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 입술 포진용 치료약 시장예측 2021년-2026년
LPI-2108K200023 / LP Information / 2021년 8월 / 본 조사보고서는 입술 포진용 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Herpes Labialis Drugs will have significant change from previous year. By the most conservative estimates of global Herpes Labialis Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 동물용 통증 관리약 시장예측 2021년-2026년
LPI-2108K201967 / LP Information / 2021년 8월 / 본 조사보고서는 동물용 통증 관리약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Veterinary Pain Management Drugs will have significant change from previous year. By the most conservative estimates of global Veterinary Pain Management Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx...

세계의 정신 장애 치료약 시장예측 2021년-2026년
LPI-2108K201578 / LP Information / 2021년 8월 / 본 조사보고서는 정신 장애 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Mental Disorders Drugs will have significant change from previous year. By the most conservative estimates of global Mental Disorders Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 당뇨병 치료약 시장예측 2021년-2026년
LPI-2108K202104 / LP Information / 2021년 8월 / 본 조사보고서는 당뇨병 치료약의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2020 growth of Antidiabetic Drugs will have significant change from previous year. By the most conservative estimates of global Antidiabetic Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over...

세계의 양극성 장애 약물 시장예측 2021년-2026년
LPI-2108K202119 / LP Information / 2021년 8월 / 본 조사보고서는 양극성 장애 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2020 growth of Bipolar Disorder Drugs will have significant change from previous year. By the most conservative estimates of global Bipolar Disorder Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in...

세계의 항우울제 시장예측 2021년-2026년
LPI-2108K202103 / LP Information / 2021년 8월 / 본 조사보고서는 항우울제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아,...According to this latest study, the 2020 growth of Antidepressant Drugs will have significant change from previous year. By the most conservative estimates of global Antidepressant Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 12180 million in 2019. Over...